News & Updates

Show Multimedia Only
Score model predicts prognosis in older adults with pneumonia

Score model predicts prognosis in older adults with pneumonia

10 Aug 2024
Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma

Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma

08 Aug 2024 byStephen Padilla

In patients with relapsed/refractory multiple myeloma (RRMM) who received at least one prior line of therapy (LOT), treatment with belantamab mafodotin (belamaf) plus pomalidomide and dexamethasone (BPD) results in statistically significant and clinically meaningful progressive-free survival (PFS) compared with pomalidomide plus bortezomib and dexamethasone (PVD), as shown in the DREAMM-8 study.

Belamaf plus pomalidomide/dexamethasone improves PFS in relapsed multiple myeloma

08 Aug 2024
New risk factor identified for sudden infant death: Maternal obesity

New risk factor identified for sudden infant death: Maternal obesity

08 Aug 2024